Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Recurrence 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Mycosis Fungoides 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Infections 2Wilms Tumor 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Sezary Syndrome 1Seminoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Multiple Myeloma 1Meningitis, Cryptococcal 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1

Interventions

Cyclophosphamide 260fludarabine phosphate 163Methotrexate 124Rituximab 112Cytarabine 109Filgrastim 106fludarabine 92Busulfan 86Peripheral Blood Stem Cell Transplantation 83Etoposide 82Vincristine 80Radiotherapy 79Tacrolimus 73Mycophenolic Acid 72Antilymphocyte Serum 68Whole-Body Irradiation 66Melphalan 63Dexamethasone 63Cyclosporine 58Doxorubicin 51Prednisone 44Methylprednisolone 44Alemtuzumab 44Mercaptopurine 41Granulocyte Colony-Stimulating Factor 40pegaspargase 35Daunorubicin 34Clofarabine 33Thiotepa 31Asparaginase 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Fluconazole × Lymphoid × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡